Catherine Gaucher

Catherine Gaucher has a diverse work experience in the field of pharmacovigilance. Catherine started their career as a Lab Director at Myco-Forestis in 2003, where they managed a technician team, handled budget and resources, and conducted field follow-up surveys.

In 2005, they joined Sanofi as a Safety Data Coordinator, where they assessed and reported cases to Health Canada, developed a process for local literature surveillance, and implemented a filing and archiving system.

Catherine then moved to Novartis in 2007 and worked as a Safety Data Coordinator, managing clinical pharmacovigilance cases and interacting with study coordinators and CRA.

Starting from 2008, Catherine worked at Lundbeck in various roles. As an Associate in Global Pharmacovigilance, they were involved in safety surveillance and case review. Later, as a Safety Scientist, they managed scientific safety activities, including signal detection and literature surveillance. Catherine also ensured compliance with European regulations by restructuring the literature surveillance process.

Most recently, Catherine worked at Pharmascience since 2017. As the Global Pharmacovigilance System and Project Lead, they oversaw compliance with health authority regulations and developed and maintained the Pharmacovigilance System Master File (PSMF). In their previous role as Global Pharmacovigilance System Specialist, they prepared global documents and introduced a new report format.

Overall, Catherine Gaucher has extensive experience in pharmacovigilance, including compliance, case management, literature surveillance, and system development.

Catherine Gaucher completed their Master's degree in Biology at UQAM | Université du Québec à Montréal from 1993 to 1995. Catherine then pursued a PhD in Biology at the same institution from 1996 to 2001. In 2010, Catherine obtained a DESS - Diplôme d'études supérieures en développement du médicament (Graduate Diploma in Drug Development) at Université de Montréal, which they completed in 2014.